Clinical Trials

Multiple Myeloma

NCT07477912 2026-03-17

MSTH-CAR001

Phase 1/2 Recruiting

30 enrolled

BreastGastrointestinalLymphoidPlasma cell

Multiple Myeloma

NCT07457112 2026-03-09

EHCancer

Phase NA Completed

212 enrolled

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms

NCT07413809 2026-02-17

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

Phase 3 Recruiting

92 enrolled

Multiple Myeloma

NCT07139509 2025-11-25

UCAR-T_MM-XA

Phase 1 Recruiting

18 enrolled

Multiple Myeloma

NCT06409767 2025-09-24

ALHERT

Phase NA Recruiting

2,224 enrolled

Other hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma

NCT07014865 2025-08-29

MMYLIFE

Recruiting

190 enrolled

Multiple Myeloma, Hematologic Neoplasms

NCT07085559 2025-07-25

Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research

Phase EARLY_PHASE1 Recruiting

36 enrolled

Other hematologic neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Leukemia, Plasma Cell, Multiple Myeloma

NCT04790474 2025-07-24

IPoD-790

Phase 2 Active not recruiting

61 enrolled

Multiple Myeloma

NCT04813653 2025-07-24

Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells

Phase 1 Completed

3 enrolled

Multiple Myeloma

NCT02358980 2025-06-25

KEEPER

5 enrolled

GenitourinaryPlasma cell

Multiple Myeloma, Acute Kidney Injury

NCT06961669 2025-05-29

ECAR01

Phase NA Recruiting

18 enrolled

Multiple Myeloma, Recurrence, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06888856 2025-03-21

MMOMICS

Not yet recruiting

200 enrolled

Multiple Myeloma

NCT06838065 2025-02-20

FKTMM2022

128 enrolled

Multiple Myeloma

NCT06758713 2025-01-06

Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies

Phase 1 Recruiting

60 enrolled

Multiple Myeloma, Lymphoma, B-Cell, Hematologic Neoplasms

NCT06284395 2024-10-02

Two Schemes Response in Multiple Myeloma

Recruiting

83 enrolled

Acute-Phase Reaction, Multiple Myeloma

NCT06520176 2024-07-25

Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

Phase 3 Recruiting

99 enrolled

Multiple Myeloma

NCT06515249 2024-07-23

Integrative Therapies in Multiple Myeloma

Phase NA Recruiting

300 enrolled

Multiple Myeloma

NCT05536154 2024-03-19

Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies

Phase NA Unknown

68 enrolled

Lymphoma, Multiple Myeloma, Hematologic Neoplasms

NCT05697913 2024-03-06

Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation

Phase NA Unknown

66 enrolled

Phase NA Not yet recruiting

Multiple Myeloma, Neoplasm, Residual

NCT06262789 2024-02-16

RAT-HEMATO

264 enrolled

Leukemia, Lymphoma, Multiple Myeloma

NCT05243212 2024-01-31

Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma

Phase 1/2 Recruiting

75 enrolled

Multiple Myeloma

NCT04683393 2024-01-24

A Single-centre Prospective Study to Explore the Role of Frailty in Patients With Multiple Myeloma.

110 enrolled

Classical hematologyPlasma cell

Multiple Myeloma

NCT03619252 2022-08-31

Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents

Phase 4 Completed

36 enrolled

Multiple Myeloma, Pneumococcal Infections, Pneumonia, Pneumococcal, Febrile Neutropenia

NCT04065789 2022-01-27

KyDaR

Phase 2 Completed

41 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT04746092 2021-08-16

The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19

Unknown

630 enrolled

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT04364724 2020-04-28

CTFEA Myeloma Study

Unknown

200 enrolled

Plasma cellSarcoma

Bone Neoplasms, Fractures, Spontaneous, Multiple Myeloma, Disease Progression

NCT02773550 2020-01-18

Velcadito

Phase 4 Terminated

24 enrolled

Other hematologic neoplasmPlasma cell

Multiple Myeloma

NCT03908138 2019-11-29

RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma

Phase 4 Unknown

120 enrolled

Multiple Myeloma, Hematologic Neoplasms

NCT03601624 2018-11-14

MM-POM-2018

Phase 2 Unknown

18 enrolled

Multiple Myeloma, Recurrence, Disease Progression

NCT03322735 2017-12-29

Study of BCMA CAR-T in Multiple Myeloma

Phase 1/2 Unknown

10 enrolled

Multiple Myeloma

NCT02488382 2017-10-17

Lonquek for Autologous Stem Cell Mobilization

Phase 1/2 Unknown

24 enrolled

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT02507479 2016-04-20

Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Phase 2 Unknown

24 enrolled

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00412919 2013-12-16

Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma

Phase 2 Terminated

7 enrolled

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT01234129 2010-11-04

Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma

320 enrolled

Multiple Myeloma

NCT01171443 2010-07-28

BIPN

Unknown

30 enrolled

Multiple Myeloma

NCT00872352 2009-03-31

Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients

Phase 3 Unknown

30 enrolled

Multiple Myeloma, Peripheral Nervous System Diseases

NCT00207805 2009-01-27

The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma

Phase 3 Completed

202 enrolled